Globus Medical (GMED) Sees IPO Price of $16-$18/Share

July 17, 2012 7:28 AM EDT Send to a Friend
In an amended S-1 filing Tuesday, Globus Medical (NYSE: GMED) disclosed it will offer 11,764,705 shares at a price ranging from $16-$18 per share. Globus plans to list on the New York Stock Exchange under the ticker, "GMED."

The offering is being made through BofA Merrill Lynch, Goldman, Sachs & Co., Piper Jaffray, Leerink Swann, Canaccord Genuity, William Blair & Company, and Oppenheimer & Co.

Globus Medical a medical device company focused exclusively on the design, development and commercialization of products that promote healing in patients with spine disorders.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

IPOs

Related Entities

Piper Jaffray, William Blair, Merrill Lynch, Bank of America, S1, Canaccord Genuity

Add Your Comment